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Abstract
Graph Neural Networks (GNN) have been extensively used to extract meaningful
representations from graph structured data and to perform predictive tasks such as
node classification and link prediction. In recent years, there has been a lot of work
incorporating edge features along with node features for prediction tasks. One of
the main difficulties in using edge features is that they are often handcrafted, hard
to get, specific to a particular domain, and may contain redundant information. In
this work, we present a framework for creating new edge features, applicable to
any domain, via a combination of self-supervised and unsupervised learning. In
addition to this, we use Forman-Ricci curvature as an additional edge feature to
encapsulate the local geometry of the graph. We then encode our edge features via
a Set Transformer and combine them with node features extracted from popular
GNN architectures for node classification in an end-to-end training scheme. We
validate our work on three biological datasets comprising of single-cell RNA
sequencing data of neurological disease, in vitro SARS-CoV-2 infection, and
human COVID-19 patients. We demonstrate that our method achieves better
performance on node classification tasks over baseline Graph Attention Network
(GAT) and Graph Convolutional Network (GCN) models. Furthermore, given the
attention mechanism on edge and node features, we are able to interpret the cell
types and genes that determine the course and severity of COVID-19, contributing
to a growing list of potential disease biomarkers and therapeutic targets.
1 Introduction
Graph neural networks (GNN) have been widely used and developed for predictive tasks such as
node classification and link prediction [1] and have been shown to learn from any sparse and discrete
relational structure in data [2]. In particular, the use of similarity metrics to construct graphs from
feature matrices expands the scope of GNN applications to domains where graph structured data is not
readily available [3]. GNNs typically use message passing, or recursive neighborhood aggregation, to
construct a new feature vector for a particular node by collecting its neighbor’s feature vectors [4, 5].
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However, most GNN schemes do not use edge features in learning new representations of graphical
data.
Recently, edge features have been incorporated into GNNs to harness information describing different
aspects of the relationships between nodes [6, 7]. However, there are very few frameworks for
creating de novo edge feature vectors in a domain agnostic manner.
In this article, using Graph Attention Networks, we propose a self-supervised learning framework
that is applicable to any graphical data, in which the learned edge attention coefficients become a set
of edge features. We show that this novel approach improves GNN performance in downstream node
classification tasks and improves training. Our framework is broad in the sense that any available
metadata associated with a particular node can be fed into a self-supervised learning framework in
this manner to extract edge features.
Given the devastating impact of the coronavirus disease of 2019 (COVID-19) caused by infection of
SARS-CoV-2 and the gap in our understanding of the molecular mechanisms of the disease, we sought
to focus our efforts on COVID-19 datasets that can generate hypotheses related to these gaps [8, 9].
Our focus on single-cell transcriptomic data relating to COVID-19 was motivated by recent work
showing that Graph Attention Networks are effective at predicting disease states on an individual cell-
to-cell basis [10]. Single-cell RNA sequencing (scRNA-seq) is a technology that yields large datasets
comprising many thousands of cells’ gene expression in a variety of conditions [11, 12, 13]. However,
identifying factors important for determining an individual cell’s pathophysiological trajectory or
response to viral insult remains a challenge as single-cell data is noisy, sparse, and multi-dimensional
[14, 15]. We reasoned that our framework’s improved performance could extract useful insights into
the genes and cell types that might be important determinants of COVID-19 severity and SARS-CoV-2
infection.
Our paper makes the following contributions:
• Creation of edge features using semi-supervised learning We propose a new approach
to obtaining edge features that does not require supervision. From a feature matrix, we
use unsupervised Louvain clustering in the graph domain to obtain community labels per
node [16]. Then, using these cluster labels, we train a GAT model and use the learned edge
attention coefficients as self-supervised edge features. We show that this self-supervised
learning framework improves performance and training with two popular GNN architectures.
• Use of Forman-Ricci curvature as an edge feature We apply a novel way of describing
the local structure of a graph by weighting an edge according to the common edges that pass
through two nodes in the connection. This unsupervised learning of the graph structure can
be applied to any graph and may enable archetypal or prototypical analysis of nodes that
have high curvature.
• Use of a Set Transformer to ingest edge features and enhance interpretability In our
self-supervised framework, we use a Set Transformer to combine edge features with message
passing GNN layers in an end-to-end node classification task.
• Identification of potential genes and cell types important to SARS-CoV-2 infection and
COVID-19 severity We use attention mechanisms in the GAT layer and the Set Transformer
to propose genes and cells that can be important in determining the temporal dynamics of
infection and disease severity in COVID-19 patient samples. These genes and cell types
may provide potential therapeutic targets or markers of disease severity.
2 Related works
There is a wealth of research on Graph Neural Networks. A significant amount of work has been
focused on graph embedding techniques, representation learning and various predictive analyses
using node features. There has been recent interest in using edge features, in addition to node features,
to improve the performance of Graph Neural Networks [6, 17, 18]. Many real-world graphs already
have edge features, such as common keywords between nodes in citation networks or interaction
affinities in protein-protein interaction networks. Even for graphs that do not prima facie have
weighted edges or directions, one can construct edge features that describe the interaction between
two nodes using Jaccard similarity, common neighbor metrics such as Adamic Adar or a variety of
similarity metrics after embedding the graph. However in this work we use an unique multi–tasking
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approach in creating these edge features. We hope that this multi–tasking pre–training regime will
further the research in meta–learning in the graph domain.
Since the primary focus of our work is in biological applications, it becomes necessary to be able to
interpret the results of our network to inform further study of biology and medicine. One of the most
common and popular ways to interpret machine learning models is via Shapley values [19] and it’s
various generalizations [20]. However Shapley values require independence of features which is hard
to guarantee in general. Thus we follow the approach of [10, 21] in using attention mechanisms for
interpretability. Thus even though set2set [22] is a popular mechanism to encode sets and has been
previously used in the graph domain [23, 24], our view is that it is hard to interpret the hidden state
of a LSTM. The transformer model [25, 26], on the other hand, allows us to interpret the results by
looking at their attention heads.
GNNs have been used in biomedical research to predict medications, diagnoses, and outcomes from
graphical representations of electronic health records [27]. GNNs have also been used to predict
protein-protein and drug-protein interactions and molecular activity [28, 29, 30, 31]. However, fewer
works attempt to predict pathophysiological state on an individual cell basis. One recent work
uses GAT models to predict the disease state of individual cells derived from clinical samples [10].
However, their work ignores edge features, which may contain important information regarding cell
type and the source from which a particular cell is derived. They do not consider multiple disease
states or severity nor do they account for the confounding bias of batch effects, which may allow the
network to learn a label for an individual cell based on its origin [13]. Here, we use the information
contained within the dataset and a graph-structure that balances the batches, thus reducing the bias of
cell source while preserving biological variation [32]. As such, we believe interpreting our model
will provide information that is more biologically relevant than proposed in the previous works. To
the best of our knowledge, this is the first attempt to apply a Deep Learning model to gain insight
into multiple pathophysiological states, merging time-points, severity, and disease-state prediction
into a multi-label node classification task from single-cell data using edge features.
3 Methods
Our work consists of three parts: (1) creating new edge features via self-supervised learning and local
curvature; (2) using the edge features for downstream node classification tasks in an inductive setting
by encoding edge features via a Set Transformer and node features via message passing GNN layers;
(3) using attention coefficients to interpret our results and provide insights into our datasets.
3.1 Creating edge features via self-supervised learning
We use a combination of semi-supervised and unsupervised learning, and local graph geometry to
create new edge features. We then concatenate these vectors to create a new edge feature vector.
3.1.1 Using semi-supervised learning to create new edge features
We use semi-supervised learning to create two types of edge features.
Using labels from unsupervised clustering in the spectral domain: Our first type of edge features
rely on community detection by optimizing modularity. We use the Louvain clustering algorithm to
assign nodes to different communities, as it has been widely used in single-cell data analysis, though
it can be applied to any graph [16, 15]. We then use a GAT model to predict the community labels
per node. Finally, we extract the edge attention coefficients from the first layer using equation 13. In
this way we get an h dimensional vector, where h is the number of heads, which becomes h edge
features.
Using other node metadata: Some graphs may have node labels that are not of interest for a
particular task. For example, in single-cell data, cells from different patients, experiments, or sources
are referred to as “batches” and are pooled into one dataset. In our datasets, we use the batch label for
an individual cell as additional input for self-supervised learning. Using the same method as before,
we construct an h-dimensional vector from the GAT model after batch label prediction.
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3.1.2 Forman-Ricci curvature
We now use the internal geometry of the graph to create our next edge feature. We use the discrete
version of the Ricci curvature as introduced by Forman [33] and discussed in [34].
RicF (e) := ω(e)
(
ω(v1)
ω(e)
+
ω(v2)
ω(e)
−
∑
ev1∼v1,ev2∼v2
[
ω(v1)√
ω(e)ω(ev1)
+
ω(v2)√
ω(e)ω(ev2)
])
(1)
where e ∈ E connecting nodes v1 and v2, ω(e) is the weight of the edge e which we take to the
Euclidean distance in the PCA space, ω(vi) is the weight of the node which we take to be 1 for
simplicity and evi ∼ vi is the set of all edges connected to vi and excluding e. This is an intrinsic
invariant that captures the local geometry of the graph and relates to the global property of the graph
via a Gauss-Bonnet style result [35].
3.1.3 Create edge features via node2vec
We use a popular embedding method called node2vec [36] to embed the nodes in a d dimensional
space. We then calculate the dot product between these node embeddings as a measure of similarity.
However to be consistent with our other methods we only compute the dot product between the
nodes which share an edge. node2vec embeddings preserve the local community structure of a graph,
which we expect should provide information to enable enhanced discriminability between nodes, as
previously suggested [37].
3.2 Models
In this subsection we describe our model, which consists of two components: (1) A Set Transformer
and (2) Message passing GNNs, like GCN or GAT layers.
Thus our model is quite general and is readily applicable with a wide variety of architectures. Since
we use a GAT model to do feature extraction to create the edge features, we will describe the GAT
model in detail below.
3.2.1 Set Transformer
We use a Set Transformer as in [26]. The Set Transformer is permutation invariant so it is an ideal
architecture to encode sets. The building block of our Set Transformer is the multi-head attention, as
in [25]. Given n query vectors Q of dimension dq , a key-value pair matrix K ∈ Rnv×dq and a value
matrix V ∈ Rnv×dv and, assuming for simplicity that dq = dv = d, then the attention mechanism is
a function given by the following formula:
att(Q,K, V ) := softmax(
QKT√
d
)V (2)
This multihead attention is computed by first projecting Q,K, V onto h different dhq , d
h
q , d
h
v dimen-
sional vectors where, for simplicity, we take dhq = d
h
v =
d
h
Multihead(Q,K, V ) := concat(O1, · · · , Oh)WO (3)
where
Oj = att(QW
Q
j ,KW
K
j , V W
V
j ) (4)
andWQj ,W
K
j ,W
V
j are projection operators of dimensionsRdq×d
h
q ,Rdq×d
h
q andRdv×dhv respectively
and WO is a linear operator of dimension d × d. Now, given a set S, the Set Transformer Block
(STB) is given the following formula:
STB(S) := LayerNorm(X + rFF (X)) (5)
where
X = LayerNorm(S + Multihead(S, S, S)) (6)
rFF is a row-wise feedforward layer and LayerNorm is layer normalization [38].
A Set Transformer takes as input a 3d tensor of the form [batch, seq-length, input-dim] and outputs
3d tensor of the form [batch, seq-length, output-dim], i.e. it outputs sets of the same size as the input
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sets. If, for a batch bi, the set transformer outputs a set of the form {wi1, ....wij}, we modify the
output of the transformer to a fixed length vector
wi :=
∑
j
λjwij (7)
where λj are learnable weights. This step is necessary for us because our downstream tasks require
vectors of fixed length.
3.2.2 Graph Attention Network
We use the popular Graph Attention Network (GAT) for extracting features from our auxiliary
tasks. We follow the exposition in [31]. The input to a GAT layer are the node features, h =
{h1, h2, ..., hN}, where hi ∈ RF , N is the number of nodes, and F is the number of features in
each node. The layer produces a new set of node features (of possibly different dimension F ′) as its
output, h′ = {h′1, h′2, ....h′N} where h′i ∈ RF
′
. The heart of this layer is multi-head self-attention
like in [25, 31]. Self-attention is computed on the nodes
al : RF
′ × RF ′ → R (8)
that computes attention coefficients, where a is a feedforward network.
elij = a
l(Wlhi,Wlhj) (9)
where Wl is a linear transformation and also called the weight matrix for the head l. We then
normalize these attention coefficients.
αlij = softmaxj(e
l
ij) =
exp(elij)∑
k∈Ni exp(e
l
ik)
(10)
where Ni is a 1-neighborhood of the node i. The normalized attention coefficients are then used
to compute a linear combination of the features corresponding to them, to serve as the final output
features for every node (after applying a nonlinearity, σ):
hli = σ
( ∑
j∈Ni
αlijWlhj
)
. (11)
We concatenate the features of these heads to produce a new node feature, h′i := ||hli.
However, for the final prediction layer, we average the representations over the heads and apply a
logistic sigmoid non-linearity. Thus the equation for the final layer is:
h′i = σ
(
1
K
K∑
l=1
∑
j∈Ni
αlijWlhj
)
. (12)
where K is the number of heads.
Our new edge features Λij for the node eij are created by concatenating the αlij across all heads, i.e.
Λij := ||Kl=1αlij (13)
Thus we end up with a K-dimensional edge feature by this method.
3.2.3 Our model
In this section we will describe our model that combines edge features, obtained as described above,
with node features for our main node classification tasks. We use a message passing networks to
encode the node features. For example, for all of our experiments, we use either two GCN or two
GAT layers. In the case of the GAT layers, we concatenate the representations obtained by different
heads. For each node i, we construct a set Si := {eij : j ∈ Ni}, where eij is the vector representing
the edge features of the edge connecting nodes i and j. We then encode this set, Si, which we call the
edge feature set attached to the node i via our modified Set Transformer. This fixed length vector is
concatenated with the node representation obtained after the second GCN or GAT layer. We call this
new representation an enhanced node feature vector. This enhanced node feature vector is then passed
through a dense layer with a logistic sigmoid non-linearity for classification. Figure 1A describes our
model architecture which uses edge features, connectivity, and node features for node classification
in an inductive setting.
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Figure 1: Our framework and datasets of interest. (A) Overview of our approach with respect to gaining
molecular and cellular insights into COVID-19. (B) Our framework and models’ architecture, integrating edge
features with GNNs via a Set Transformer. (C) Graphical data used, showing cell types for each cell and edges
in a node-feature, dimension-reduced embedding.
Table 1: Dataset description showing train/val/test splits.
Datasets SARS-CoV-2infected organoids COVID-19 patients Multiple sclerosis patients
# Nodes 54353/11646/11648 63486/13604/13605 53280/19980/11988
# Node features 24714 25626 22005
# Edges 1041226/230429/228630 2746280/703217/707529 6871820/2635746/1602662
# Edge features 18 18 18
# Classes 7 3 2
4 Experiments
We validate our model on the following scRNA-seq datasets:
• 4 human bronchial epithelial cell cultures or “organoids” that were inoculated with SARS-
CoV-2 and co-cultured for 1, 2, and 3 days post-infection [39].
• Bronchoalveolar lavage fluid samples from 12 patients enrolled in a study at Shenzen Third
People’s Hospital in Guangdong Province, China of whom 3 were healthy controls, 3 had a
mild or moderate form of COVID-19 and 6 had a severe or critical COVID-19 illness [40].
• Blood and CSF samples from 13 patients of whom 6 were healthy controls and 7 had
multiple sclerosis, a neurological disease [10].
Table 2: Experimental tasks
Task SARS-CoV-2infected organoids COVID-19 patients Multiple sclerosis patients
Louvain cluster ID Cell type Cell type Cell type
Batch or node metadata Culture sample ID Patient ID Patient ID + sample type
Inductive prediction Timepoint and infection No, Mild, or Severe Disease MS or Healthy
See table 1 for a summary of our datasets. For all the datasets we create a Batch-Balanced
kNN graph to remove the confounding bias of experimental or sequencing differences between
samples [41]. For more details about data pre-processing and graph construction from single cell data,
please refer to the supplementary material. Table 2 details all the tasks that we perform on our datasets.
Auxiliary tasks : We first describe our auxiliary tasks which we devise to create new edge
features. We cluster our datasets using Louvain clustering [16], and annotate these clusters as “cell
types,” as commonly done in single-cell analysis [15]. Then, we use a 2-layer GAT with 8 attention
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heads in each layer to predict the cell type label. We extract the edge attention coefficients from
the first layer of our trained model as edge features. Thus we get an 8-dimensional edge feature
vector by equation 13. All of our biological datasets have a batch ID associated to it, i.e. some
metadata that keeps track of the origin of the cell. We use the same method as before to create
another 8-dimensional edge feature vector. More details and results about the auxiliary tasks can be
found in the supplementary material.
Main tasks : Our final task is node label prediction in an inductive setting, as shown in 2.
All the results shown are from the test set and our model’s performance is reported in table 3.
Our model outperforms the baseline models by a significant margin. We note that our results on
the MS dataset differ from the results as reported in [10] since we use a different graph kernel
(BB-kNN kernel [32]), which reduces bias due to technical measurement artifacts of the data. We
also calculated the p-value (Welch’s t-test) between our model and the baseline GAT and GCN
models. The p-value was < .001 for all the experiments showing that our models are a significant
improvement over the baseline.
Table 3: Results of inductive tasks on single-cell datasets showing accuracy and 95% confidence intervals.
Models SARS-CoV-2infected organoids
COVID-19
patients
Multiple sclerosis
patients
P
(Welch’s t-test)
GCN 65.43 (65.21-65.65) 89.26 (89.06-89.47) 73.23 (72.93-73.53) -
GCN + Edge Features (Ours) 81.61 (79.34-83.87) 92.84 (91.95-93.74) 85.06 (83.85-86.28) < 0.001
GAT 73.10 (70.93-75.27) 92.25 (91.27-93.24) 73.03 (72.22-73.83) -
GAT + Edge Features (Ours) 82.95 (81.75-84.15) 95.12 (94.02-96.22) 85.03 (84.34-85.72) < 0.001
Other than improved performance we found that our model trains faster than the baseline GCN and
GAT models. We compared the loss per epoch for baseline GCN and GAT models versus our models.
Broadly, our model achieves significant and consistently lower loss per epoch and requires fewer
epochs to train, as shown in Figure 2.
Figure 2: Negative log likelihood losses per epoch for training models for our COVID-19 datasets.
5 Model Interpretability
In addition, we extract the learned weights from the GAT layer to investigate our model’s feature
saliency with respect to gene importance in predicting SARS-CoV-2 infection and COVID-19 severity.
In predicting COVID-19 severity from patient samples, our model gives high weight to genes involved
in the innate immune system response to type I interferon (CCL2, CCL7, IFITM1), regulation of
signaling (NUPR1, TAOK1, MTRNR2L12), a component of the major histocompatibility complex II
(HLA-DQA2), which is important for developing immunity to infection, and a marker of eosinophil
cells, which are involved in fighting parasites (RETN). In predicting SARS-CoV-2 infection, our
model finds saliency in counts of viral transcript, which is encouraging. In addition, to predicting
SARS-CoV-2, genes involved in inflammatory response and cell death (NFKBIA) and interferon
signaling (IFI27) appear to be important, as does signaling, which may provide clues as to the
dynamic response to SARS-CoV-2 infection in the lung’s airways (IFI27, HCLS1, NDRG1, NR1D1,
TF).
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Figure 3: Model interpretability to generate hypotheses for genes and cells important to COVID-19 severity.
(A) Embedding learned from graphs extracted from average edge attentions across Set Transformer output
dimensions, showing cell type or condition per cell. (B) Relative importance of crafted edge features in disease
state prediction tasks, averaged across the query layer from the Set Transformer. (C) Top 5 important gene
features for each GAT head, colored by normalized, learned weights.
Using the edge attentions from the Set Transformer, we construct a new graph and perform unsu-
pervised clustering and manifold learning [42, 16]. We obtain distinct cell clusters of SARS-CoV-2
infected cells which are also segregated by cell type. These cells may have unique behaviors that
warrant further analysis. The learned embedding for the organoids dataset highlights that our model
segregates infected ciliated cells, which is the reported SARS-CoV-2 cell tropism, validating our
models’ interpretability [39]. In predicting COVID-19 severity, it is interesting that our model learns
to mix macrophages and monocytes in a predominantly severe patient cell cluster while cells derived
from mild and severe patients are mixed in a T cell cluster. Monocytes derived from macrophages
are thought to be enriched in severe COVID-19 cases and T cells are proposed targets for immune
checkpoint therapy of COVID-19, despite lack of understanding as to the transcriptional differences
between mild and severe COVID-19 illness [43, 40, 44]. Lastly, our models find that genes involved
in type I interferon signaling are important in predicting both COVID-19 severity and susceptibility
to SARS-CoV-2 infection. Interferon signaling is involved in pro-inflammatory immune responses
and it is suspected that type I interferon signaling may cause immunopathology during SARS-CoV-2
infection leading to critical illness [39, 44].
6 Discussion
We achieved significant performance enhancements using self-supervised edge features when com-
paring two popular GNN architectures, GCN and GAT models, to our architecture that builds on
those models. This suggests that using edge features derived from self-supervised learning and
local graph information, with no requirement for hand-crafted edge features, can improve graph
neural network performance on challenging node classification tasks. Our models are simple, easy
to train and can be used with various graph neural architectures and our edge creation framework
is applicable to any graphical data. This flexibility may benefit training and performance, as we
show with three biological datasets, but will also expand interpretability to local geometry of the
graph using Forman-Ricci curvature. We anticipate that in the future, this metric will help with local
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explanations of decision boundaries in GNNs. Finally as a future direction we hope to pursue our
multi–tasking approach for meta-learning in the graph domain.
Our model allows us to gain insights into the cell tropism of SARS-CoV-2 and to elucidate the genes
and cell types that are important for predicting COVID-19 severity. We are encouraged to find that
genes involved in regulating the immune system are important for predicting SARS-CoV-2 infection
and COVID-19 severity. Given the inclusion of edge features and cell types in our model, we are also
encouraged that we identified clusters of cells that may be involved in immunopathology [44, 39].
Further study into the interaction partners and the subtle transcriptional differences between the
cells and cell types we identified may provide complementary hypotheses or avenues for therapeutic
intervention to mitigate the impacts of COVID-19.
7 Broader Impact
The impact of the COVID-19 pandemic is tragic and its extent is still unknown. Here, we attempt
to bring accurate disease state prediction to a molecular and cellular scale so that we can identify
the cells and genes that are important for determining susceptibility and resistance to SARS-Cov-2
infection and severe COVID-19 illness via interpreting our models. To the best of our knowledge,
no deep learning method can perform as well as we have on predicting multiple disease-states for a
single-cell sample. Typically, biologists rely on identifying cells by clustering and dimensionality
reduction and compare their differential gene expression to identify molecular determinants of disease.
However, this is often done without checking if the differences are meaningful or predictive, which
we do here. In addition, identifying the cells, cell types, and genes that are important for SARS-CoV-2
infection and COVID-19 severity contributes a long list of potential biomarkers for disease state
diagnosis and therapeutic targets for further investigation. However, there are many caveats to our
study. While we achieve good performance with our models, model interpretability in artificial neural
networks does not have a strong theoretical basis, and any proposed features should merely be thought
of as putative hypotheses into the mechanisms of viral insult. In addition, cells in the COVID-19
patient and MS patient datasets are derived from a relatively small patient population, albeit large
for single-cell or clinical studies. While we, for the first time, attempt to limit this bias by using
a batch-balanced kNN graph, which we also think makes it more likely that our framework learns
from biological variability, we remain vulnerable to the idiosyncrasies of the samples. Thus, any
potential feature that identified as important for prediction should only be considered meaningful
after extensive experimental validation. We are not medical professionals so we do NOT claim that
interpretation of our model will bear any fruit. Rather, we hope that the approach of seeking excellent
and state-of-the-art predictive results on disease states at single-cell resolution will enhance study of
biology and medicine and potentially accelerate our understanding of critical diseases during crises
like the COVID-19 pandemic.
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A Data pre-processing
A.1 Feature matrix preparation
Prior to graph creation, all samples were processed with the standard single-cell RNA-sequencing
pre-processing recipe using Scanpy [57, 71]. Cells and genes for the MS dataset were pre-processed
as described in [10]. For the SARS-CoV-2 infected organoids and COVID-19 patients datasets, genes
expressed in fewer than 3 cells and cells expressing fewer than 200 genes were removed but, to
allow for characterization of stress response and cell death, cells expressing a high percentage of
mitochondrial genes were not removed. For all single-cell datasets, transcript or ”gene” counts per
cell were normalized by library size and square-root transformed.
A.2 Graph creation
To create graphs from a cell by gene counts feature matrix, we used a batch-balanced kNN graph [41].
BB-kNN constructs a kNN graph that identifies the top k nearest neighbors in each ”batch”, effectively
aligning batches to remove bias in cell source while preserving biological variability [32]. We used
annoy’s method of approximate neighbor finding with a Euclidean distance metric in 50-dimensional
PCA space. Per ”batch” we find k = 3 top nearest neighbors. An example BB-kNN graph is
schematized in main text, Figure 1A.
Figure 4: UMAP embeddings of individual cells colored by labels for auxiliary tasks. (A) Batch labels for
SARS-Cov-2 infected organoids dataset. (B) Batch labels for COVID-19 patients, for patient IDs described
in [40]. (C) Graph used for the MS dataset with Louvain cluster labels to represent cell types (left) and batch
labels per patient sample (right).
B Hyperparameters and Training details
For auxiliary tasks and for training our models, we break our graph into 5000 subgraphs using
the ClusterData function in PyTorch Geometric library and then minibatched the subgraphs using
the ClusterData function. These algorithms are originally introduced in [49]. We used a single
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Table 4: Default hyperparameters used in the experiments
Graph Attention Network Graph Convolution Network
Number of layers 2 2
Hidden size 8 256
Attention Heads 8 N/A
Optimizer Adagrad Adagrad
weight decay .0005 .0005
Batch size 256 256
Dropout .5 .4
Slope in LeakyRelu .2 .2
Training Epochs 1000 1000
Early stopping 100 100
block of Set Transformer with input dimension 18, output dimension 8 and 2 heads. The rest of the
hyperparamaters of GAT and GCN can be found in table 4.
For our auxiliary tasks and for baseline experiments we used an 8GB Nvidia RTX2080 GPU and for
our main tasks we used an Intel E5-2660 v3 CPU with 121GB RAM.
C Auxiliary task
In this section we describe our auxiliary tasks. Table 5 gives details about the number of labels for
the auxiliary tasks. We first predict the cell types as given by the Louvain clustering [16]. In figure 4
we show Louvain community ID or cluster labels for the MS patients dataset, which can be annotated
as cell types as in [10]. In the main text, we used [72] to obtain cell type markers and annotate the
Louvain cluster labels as ”cell types” explicitly.
Next we predict the batch ID of each node, i.e. which patient or from where the cell is obtained.
Table 6 shows our results for these auxiliary tasks. In single-cell RNA-sequencing, variability between
batches can explain more of the transcriptomic variability than variability in the biological process
of interest; these ”batch effects” can complicate model inference [15]. Our novel use of BB-kNN
graphs for the tasks described in this paper limits this ”batch effect” bias.
Table 5: Number of labels for auxiliary tasks
Task SARS-CoV-2infected organoids COVID-19 patients Multiple sclerosis blood & CSF
Cell type 8 10 27
Batch 4 12 26
Table 6: Results on auxiliary tasks
Prediction SARS-CoV-2infected organoids COVID-19 patients Multiple sclerosis blood & CSF
Cell type 93.84 82.03 75.90
Batch 76.16 64.08 36.21
D Code and Data Availability
The processed data for SARS-CoV-2 infected organoids samples and the COVID-19 patient samples
can be found at this link. We do not have the permission to share the MS patient data, as it belongs to
a third party. All code used to reproduce these results are available in the associated supplementary
material and will be published on GitHub post-review.
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